Clorox (CLX) Tops Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Clorox (CLX) 1Q16 EPS Beat Driven by Top-Line Growth; UBS Raises Price Target to $105
November 3, 2015 8:43 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $105.00 (from $103.00), following the company's 1Q16 earnings results. CLX posted a sizeable Q1 beat, delivering $1.32 in EPS (20% YOY growth) vs. consensus of $1.18. This outperformance was driven by greater FX-neutral top-line... More
